The researchers found that compare to ordinary formula, weaning to an insulin-free formula (FINDIA group) reduced the cumulative incidence of autoantibodies by age 3 years in children at genetic risk of T1D. This evidence concerns the gene INS and type 1 diabetes mellitus.